# Celtaxsys

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/celtaxsys

- Industry: Pharmaceuticals
- Headquarters: Atlanta, US
- Website: www.celtaxsys.com
- Total disclosed funding: $22M
- Latest round: Series E (Dec 18, 2017)
- Investors on record: 6

## About

Founded in 2007 and based in Georgia, US, Celtaxsys, Inc. is a pharmaceutical development company focused on novel therapeutics that treat inflammatory disease through regulation of immune cell migration and activation.

## Funding rounds

- Series E, Dec 18, 2017 — Domain Associates, Invus [DUP], Masters Capital, GRA Venture Fund, RMI Partners, Lumira Ventures
- Series D, Jun 8, 2015, $22M — Domain Associates, Masters Capital, GRA Venture Fund, RMI Partners, Lumira Ventures

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series D, Series E
- Masters Capital — Series D, Series E
- GRA Venture Fund (https://capitalatlas.ai/funds/gra-venture-fund) — Series D, Series E
- RMI Partners (https://capitalatlas.ai/funds/rmi-partners) — Series D, Series E
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series D, Series E
- Invus [DUP] — Series E